Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-29 Purchase(A) | 2024-04-09 7:08 pm | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 400,000 | $19 | $7,600,000 | 4,958,810 (Direct) | View |
2024-01-29 Purchase | 2024-01-31 4:17 pm | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 400,000 | $19 | $7,600,000 | 4,958,812 (Indirect Direct) | View |
2023-11-09 Purchase | 2023-11-14 5:33 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 375,000 | $12.5 | $4,687,500 | 7,083,288 (Indirect) | View |
2021-09-17 Purchase | 2021-09-21 5:12 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 1,542,553 | $9.4 | $14,499,998 | 4,708,288 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-09 Option Award | 2024-04-11 9:01 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Cui Xiangmin Director | 6,172,344 | $0 | 4,183,002 (Indirect) | View |
2024-01-29 Conversion | 2024-01-31 4:17 pm | N/A N/A | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 38,223,094 | $0 | 4,958,812 (Direct) | View |
Ownership | 2024-01-24 8:26 pm | N/A N/A | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 4,558,810 (Direct) | View |
2024-01-18 Exercise | 2024-01-22 5:48 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 1,234,636 | $0 | 8,317,924 (Indirect) | View |
2024-01-18 Exercise | 2024-01-22 5:48 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 1,234,636 | $12.74 | 8,317,924 (Indirect) | View |
2024-01-02 Option Award | 2024-01-04 7:03 pm | N/A 2034-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 17,500 | $0 | 17,500 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 6:55 pm | N/A 2033-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
2022-09-23 Option Award | 2022-09-27 4:51 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 2,000,000 | $7.35 | 1,360,544 (Indirect) | View |
2022-01-03 Option Award | 2022-01-04 5:17 pm | N/A 2032-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
2021-09-28 Conversion | 2021-09-30 5:43 pm | N/A N/A | Cue Health Inc. | HLTH | Cui Xiangmin Director | 8,192,468 | $0 | 788,441 (Indirect) | View |
2021-09-28 Option Award | 2021-09-30 5:43 pm | N/A N/A | Cue Health Inc. | HLTH | Cui Xiangmin Director | 788,441 | $12.8 | 788,441 (Indirect) | View |
Ownership | 2021-09-23 9:06 pm | N/A N/A | Cue Health Inc. | HLTH | Cui Xiangmin Director 10% Owner | 0 | $0 | 8,192,468 (Indirect) | View |
Ownership | 2021-09-23 9:06 pm | N/A N/A | Cue Health Inc. | HLTH | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 8,192,468 (Direct) | View |
Ownership | 2021-02-16 5:22 pm | N/A N/A | Equillium Inc. | EQ | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 4,271,423 (Indirect) | View |
2021-01-04 Option Award | 2021-01-05 7:06 pm | N/A 2031-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 7,650 | $0 | 7,650 (Direct) | View |
2020-01-02 Option Award | 2020-01-06 8:01 pm | N/A 2030-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Director 10% Owner | 7,650 | $0 | 7,650 (Direct) | View |